| Net Income Per Share |
Net Income (Loss) Per Share For the periods presented, the following table reconciles the denominators used in the basic and diluted net income (loss) per share calculations (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Denominator for basic calculation | 225,305 | | | 242,326 | | | 229,589 | | | 241,889 | | | Effect of dilutive securities: | | | | | | | | | Option awards | — | | | 10,126 | | | — | | | 9,149 | | | Unvested restricted stock units | — | | | 3,791 | | | — | | | 3,662 | | | | | | | | | | Denominator for dilutive calculation | 225,305 | | | 256,243 | | | 229,589 | | | 254,700 | |
For the periods presented, the following Class C capital stock equivalents were excluded from the calculations of diluted net income (loss) per share because their effect would have been antidilutive (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Weighted-average capital stock option awards outstanding | 684 | | | 2,724 | | | 7,731 | | | 3,225 | | | Weighted-average capital stock restricted stock units outstanding | 12,234 | | | 109 | | | 11,619 | | | 1,922 | | | Capital stock issuable upon conversion of the 2025 Notes | — | | | — | | | — | | | 3,084 | | | Total capital stock equivalents | 12,918 | | | 2,833 | | | 19,350 | | | 8,231 | |
|